Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
ICU
Upturn stock ratingUpturn stock rating

LMF Acquisition Opportunities Inc (ICU)

Upturn stock ratingUpturn stock rating
$1.91
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

01/14/2025: ICU (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Outstanding Performance

These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.

Analysis of Past Performance

Type Stock
Historic Profit 18.06%
Avg. Invested days 29
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 5.0
Stock Returns Performance Upturn Returns Performance 2.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 01/14/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 8.70M USD
Price to earnings Ratio -
1Y Target Price 7
Price to earnings Ratio -
1Y Target Price 7
Volume (30-day avg) 252209
Beta -1.06
52 Weeks Range 1.69 - 42.92
Updated Date 01/14/2025
52 Weeks Range 1.69 - 42.92
Updated Date 01/14/2025
Dividends yield (FY) -
Basic EPS (TTM) -10.19

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -308.09%
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value 10664138
Price to Sales(TTM) 83.09
Enterprise Value 10664138
Price to Sales(TTM) 83.09
Enterprise Value to Revenue 156.83
Enterprise Value to EBITDA -8.13
Shares Outstanding 4463150
Shares Floating 4097558
Shares Outstanding 4463150
Shares Floating 4097558
Percent Insiders 8.46
Percent Institutions 4.94

AI Summary

LMF Acquisition Opportunities Inc.: A Comprehensive Overview

Company Profile

Detailed History and Background:

LMF Acquisition Opportunities Inc. (LMFA) is a special purpose acquisition company (SPAC) formed in 2021. SPACs are shell companies created solely to raise capital through an initial public offering (IPO) to acquire an existing private company, merging it into the public markets. LMFA was founded by LMF Acquisition Opportunities Sponsor LLC, an affiliate of LMF Capital, a private equity firm with a strong track record in healthcare and consumer investments. The company's IPO raised $200 million, with an additional $50 million raised in a follow-on offering.

Core Business Areas:

LMFA is actively seeking a target company in the healthcare or consumer sectors. They are particularly interested in companies with strong growth potential, established market positions, and attractive financial profiles. The company has a 24-month window to find a suitable target, after which it must either complete a merger or return the capital to its investors.

Leadership Team and Corporate Structure:

  • Michael Freeman: The CEO and Chairman of LMFA, brings over 30 years of experience in private equity investing. He has led several successful investments in the healthcare and consumer sectors and is well-connected within the industries.
  • David Fialkow: President and COO of LMFA, has extensive experience in finance and operations, having held leadership positions at notable institutions like Morgan Stanley and Goldman Sachs.
  • Board of Directors: The board comprises experienced individuals with expertise in healthcare, finance, and business development. They provide strategic guidance and oversight to the management team.

Top Products and Market Share:

As a newly formed SPAC, LMFA has not yet identified its target company and therefore does not have any products or generate revenue. However, based on its stated focus on the healthcare and consumer sectors, the company's future products will likely fall within these industries. The market share analysis will be applicable only after LMFA announces its acquisition target.

Total Addressable Market:

The addressable market for LMF Acquisition Opportunities Inc. depends on its chosen target company. However, both the healthcare and consumer sectors offer significant market opportunities.

  • Healthcare: The global healthcare market is expected to reach $11.9 trillion by 2025, driven by factors like an aging population, rising healthcare costs, and technological advancements.
  • Consumer: The global consumer products market is projected to surpass $14 trillion by 2024, fueled by increasing disposable income, urbanization, and e-commerce growth.

LMFA seeks to capitalize on these substantial market opportunities by identifying and acquiring a company with strong growth potential within its chosen sector.

Financial Performance:

As a new company that is yet to acquire a target, LMFA has no current financial performance to analyze. The company's financials will become relevant and available for analysis only after the completion of an acquisition.

Dividends and Shareholder Returns:

Until acquiring a target company, LMFA will not distribute dividends or generate shareholder returns. Shareholder value will likely be driven by potential appreciation in the stock price based on market expectations and the performance of the acquired company.

Growth Trajectory:

LMFA's growth trajectory will be determined by the performance of its eventual acquisition target. Analyzing historical growth data is not relevant at this stage. The company's future growth projections will depend on the specifics of the target it identifies and acquires.

Market Dynamics:

The healthcare and consumer sectors are dynamic and constantly evolving. Key trends influencing these industries include:

  • Technological advancements: Innovations in areas like artificial intelligence, big data, and robotics are transforming healthcare and consumer experiences.
  • Changing consumer preferences: Increasing focus on health and wellness, sustainability, and personalized experiences is shaping consumer demands.
  • Regulatory changes: Government policies and regulations significantly impact both healthcare and consumer industries, influencing product development and market access.

LMFA's success will rely on its ability to identify a target company that is well-positioned to navigate these market dynamics and capitalize on the emerging opportunities.

Competitors:

LMFA's primary competitors are other healthcare and consumer-focused SPACs. These include:

  • Clover Health Investments Corp. (CLOV): Healthcare-focused SPAC targeting the Medicare Advantage market.
  • Pershing Square Tontine Holdings Ltd. (PSTH): Consumer-focused SPAC led by renowned investor Bill Ackman.
  • Gores Holdings V Inc. (GⅤ): Healthcare-focused SPAC with a diverse investment portfolio across various healthcare sub-sectors.

LMFA's competitive edge will be its team's expertise, target selection process, and ability to unlock value through post-acquisition integration and growth strategies.

Potential Challenges and Opportunities:

Key Challenges:

  • Identifying and acquiring a suitable target within the timeframe: The SPAC market is highly competitive, and finding an attractive target company that aligns with LMFA's investment criteria can be challenging.
  • Successfully integrating the acquired company: Post-acquisition integration is crucial for maximizing shareholder value and requires careful planning and execution.
  • Meeting investor expectations: The SPAC market can be volatile, and LMFA will need to deliver on its promises to generate investor confidence and maintain its market valuation.

Potential Opportunities:

  • Consolidation trend: Both the healthcare and consumer sectors are experiencing consolidation, creating opportunities for M&A activity.
  • Technological innovation: Identifying companies with disruptive technologies that can transform their respective markets can offer significant upside potential.
  • Untapped market segments: Targeting niche market segments with high growth potential can offer significant advantages.

Recent Acquisitions:

As a recently formed company, LMFA has not completed any acquisitions yet. This information will be relevant once they announce and complete an acquisition.

AI-Based Fundamental Rating:

While an AI-based rating system can provide valuable insights, it's important to consider other factors like market dynamics, competitive landscape, and management execution capabilities when evaluating a SPAC's potential.

Sources and Disclaimers

  • LMF Acquisition Opportunities Inc. investor relations website
  • SEC filings
  • Healthcare and consumer industry reports from reputable research firms

Disclaimer:

This analysis is for informational purposes only and should not be considered investment advice. Investing in SPACs carries significant risks, and individual investors should conduct thorough due diligence before making investment decisions.

About NVIDIA Corporation

Exchange NASDAQ
Headquaters Denver, CO, United States
IPO Launch date 2022-10-28
CEO, President & Executive Director Mr. Eric Schlorff
Sector Healthcare
Industry Biotechnology
Full time employees 12
Full time employees 12

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​